Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis
Clinical trial NCT01358578 · COMPLETED
Trial details
- NCT number
- NCT01358578
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-07-01
- Enrollment
- 1306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.